✦ LIBER ✦

Successful oral valganciclovir treatment of cytomegalovirus infection during Campath-1H therapy

✍ Scribed by González, H; Vernant, J P; Caumes, E

Book ID: 110056159
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 56 KB
Volume: 19
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403636

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment with oral valgancic

Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection

✍ Buonuomo, P S; Maurizi, P; Valentini, P; Mastrangelo, S; Lazzareschi, I; Ridola, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 45 KB

188: Development of Cytomegalovirus (CMV

188: Development of Cytomegalovirus (CMV) Infection during Ongoing Valganciclovir Therapy

✍ J. Patel; M. Kittleson; B. Kubak; M. Kawano; S. Davis; J. Moriguchi; A. Ardehali 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Emergence of antiviral resistance during

Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection

✍ Choi, K. Yeon; Sharon, B.; Balfour, H.H.; Belani, K.; Pozos, T.C.; Schleiss, M.R 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 874 KB

Successful valganciclovir treatment of p

Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D

✍ Jenna M. Iwasenko; Gillian M. Scott; William D. Rawlinson; Anne Keogh; Daniel Mi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract Mutations in the human cytomegalovirus (CMV) UL97 protein kinase are the most common mechanism of ganciclovir (GCV) resistance in the clinical setting. A CMV strain with a previously unrecognized UL97 mutation N597D was identified in the blood of a heart transplant recipient who experie

Treatment of symptomatic congenital cyto

Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir

✍ Jacob Amir; Dana G. Wolf; Itzhak Levy 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 135 KB

Resistance pattern of cytomegalovirus (C

Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection

✍ David Boutolleau; Claire Deback; Céline Bressollette-Bodin; Shaida Varnous; Nath 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 165 KB